scholarly journals Obstructive Sleep Apnea Affects Hospital Outcomes of Patients with non-ST-Elevation Acute Coronary Syndromes

SLEEP ◽  
2012 ◽  
Vol 35 (9) ◽  
pp. 1241-1245 ◽  
Author(s):  
Luis C. L. Correia ◽  
Alexandre C. Souza ◽  
Guilherme Garcia ◽  
Michael Sabino ◽  
Mariana Brito ◽  
...  
2010 ◽  
Vol 55 (10) ◽  
pp. A119.E1116 ◽  
Author(s):  
Luis Correia ◽  
Alexandre C. Souza ◽  
Jamile Leal ◽  
Maria C. Almeida ◽  
Rafael Freitas ◽  
...  

2014 ◽  
Vol 16 (10) ◽  
Author(s):  
B. Cepeda-Valery ◽  
S. Acharjee ◽  
A. Romero-Corral ◽  
G. S. Pressman ◽  
A. S. Gami

Hearts ◽  
2021 ◽  
Vol 2 (1) ◽  
pp. 119-126
Author(s):  
Sakiru Oyetunji Isa ◽  
Oluwole Adegbala ◽  
Olajide Buhari ◽  
Mahin Khan ◽  
Orimisan Adekolujo ◽  
...  

Background: Obstructive sleep apnea (OSA) is one of the most common breathing disorders. There are uncertainties about its impact on the in-hospital outcomes of patients who suffer acute coronary syndromes. We studied the largest publicly available all-payer inpatient healthcare database in the United States (National Inpatient Sample) to determine the effects of obstructive sleep apnea on the in-hospital outcomes of patients admitted with non-ST elevation myocardial infarction (NSTEMI). Methods: All adult patients (age ≥ 18) admitted primarily for NSTEMI between September 2010 and September 2015 were identified in the National Inpatient Sample. They were then categorized into those with OSA and those without OSA. The main outcome was in-hospital mortality. Propensity scoring and logistic regression models were created to determine the outcomes. Results: There were 1,984,432 patients with NSTEMI (weighted estimates), 123,551 (6.23%) of who had diagnosed OSA while 1,860,881 (93.77%) did not. In-hospital mortality was significantly lower in the OSA group [2.61% vs. 3.53%, adjusted odd ratio (aOR) 0.73 and confidence interval (CI) (0.66–0.81)]. Patients with OSA were also less likely to require coronary artery bypass surgery: 13.85% and 12.77% (p-value 0.0003). The patients with OSA had higher mean hospital costs compared to the patients who did not have OSA: $17,326 vs. $16,984, adjusted mean ratio (aMR) 1.02; CI (1.01–1.02). Conclusion: In-hospital mortality was lower in NSTEMI patients with diagnosed OSA compared to patients without diagnosed OSA. This appears to contrast with the widely recognized adverse effects of OSA on the cardiovascular system.


2016 ◽  
Vol 8 (1) ◽  
pp. 13
Author(s):  
Afef Ben Halima ◽  
Lobna Laroussi ◽  
Houda Gharsalli ◽  
Zied Belhadj ◽  
Karim Fareh ◽  
...  

2020 ◽  
Vol 9 (4) ◽  
pp. 989
Author(s):  
Colin Suen ◽  
Jean Wong ◽  
Clodagh M. Ryan ◽  
Samuel Goh ◽  
Tiffany Got ◽  
...  

Background: Obstructive sleep apnea (OSA) is associated with long-term cardiovascular morbidity and is highly prevalent in patients with cardiovascular disease (CVD). The objectives of this scoping review were to determine the prevalence of OSA inpatients hospitalized for CVD and to map the range of in-hospital outcomes associated with OSA. Methods: We searched MEDLINE(R), Embase, and Cochrane Databases for articles published from 1946–2018. We included studies involving non-surgical adults with OSA or at high risk of OSA who were hospitalized for CVD. The outcomes were considered as in-hospital if they were collected from admission up to 30 days post-discharge from hospital. Results: After the screening of 4642 articles, 26 studies were included for qualitative synthesis. Eligible studies included patients presenting with acute coronary syndromes (n = 19), congestive heart failure (n = 6), or any cardiovascular disease (n = 1). The pooled prevalence of OSA in cardiac inpatients was 48% (95% CI: 42–53). The in-hospital outcomes reported were mortality (n = 4), length of stay (n = 8), left ventricular ejection fraction (n = 8), peak troponin (n = 7), peak B-type natriuretic peptide (n = 4), and composite cardiovascular complications (n = 2). Conclusions: OSA is highly prevalent in the cardiac inpatient population. The outcomes reported included mortality, cardiac function, cardiac biomarkers, and resource utilization. There are significant knowledge gaps regarding the effect of treatment and OSA severity on these outcomes. The findings from this review serve to inform further areas of research on the management of OSA among patients with CVD.


2018 ◽  
Vol 71 (11) ◽  
pp. A526
Author(s):  
Mario Rodriguez ◽  
Basera Sabharwal ◽  
Chayakrit Krittanawong ◽  
Valeria Santibañez ◽  
Saman Setareh-Shenas ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document